US Patent Issued to DANA-FARBER CANCER INSTITUTE, XYONE THERAPEUTICS on Nov. 11 for "Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,895, issued on Nov. 11, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston) and XYONE THERAPEUTICS INC. (Canton, Mass.).

"Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)" was invented by Donald W. Kufe (Wellesley, Mass.) and Surender Kharbanda (Natick, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to antibodies binding to MUC1-C/extracellular domain (MUC1-C/ECD) and methods of using such antibodies to treat cancers that express the MUC1 antigen."

The patent was filed on Oct. 5, 2021, under Application No. 17/494,577.

*For further information, including images, charts and tables, pleas...